Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.
2.

Mutations in the NF-kappaB signaling pathway: implications for human disease.

Courtois G, Gilmore TD.

Oncogene. 2006 Oct 30;25(51):6831-43. Review.

PMID:
17072331
3.

NF-kappaB-related genetic diseases.

Courtois G, Smahi A.

Cell Death Differ. 2006 May;13(5):843-51. Review.

4.
5.

Regulation and function of IKK and IKK-related kinases.

Häcker H, Karin M.

Sci STKE. 2006 Oct 17;2006(357):re13. Review.

PMID:
17047224
6.

Nuclear factor kappa B signaling in macrophage function and atherogenesis.

Xanthoulea S, Curfs DM, Hofker MH, de Winther MP.

Curr Opin Lipidol. 2005 Oct;16(5):536-42. Review.

PMID:
16148538
7.

Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.

Orange JS, Levy O, Brodeur SR, Krzewski K, Roy RM, Niemela JE, Fleisher TA, Bonilla FA, Geha RS.

J Allergy Clin Immunol. 2004 Sep;114(3):650-6.

PMID:
15356572
8.

Circuitry of nuclear factor kappaB signaling.

Hoffmann A, Baltimore D.

Immunol Rev. 2006 Apr;210:171-86. Review.

PMID:
16623771
9.

Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.

Raychaudhuri B, Han Y, Lu T, Vogelbaum MA.

J Neurooncol. 2007 Oct;85(1):39-47.

PMID:
17479228
10.

Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.

Bustamante J, Boisson-Dupuis S, Jouanguy E, Picard C, Puel A, Abel L, Casanova JL.

Curr Opin Immunol. 2008 Feb;20(1):39-48. Review.

PMID:
18083507
11.

Heritable defects of the human TLR signalling pathways.

Puel A, Yang K, Ku CL, von Bernuth H, Bustamante J, Santos OF, Lawrence T, Chang HH, Al-Mousa H, Picard C, Casanova JL.

J Endotoxin Res. 2005;11(4):220-4. Review.

PMID:
16176658
12.

Nuclear factor-kappaB activation: from bench to bedside.

Sethi G, Sung B, Aggarwal BB.

Exp Biol Med (Maywood). 2008 Jan;233(1):21-31. Review.

PMID:
18156302
13.

Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.

Isomura I, Morita A.

Microbiol Immunol. 2006;50(8):559-63. Review.

14.

Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.

Park GY, Christman JW.

Curr Drug Targets. 2006 Jun;7(6):661-8. Review.

PMID:
16787168
15.

Regulation of NF-kappaB transcriptional activity.

Vermeulen L, Vanden Berghe W, Haegeman G.

Cancer Treat Res. 2006;130:89-102. Review.

PMID:
16610704
16.

NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor?

Jones WK, Brown M, Wilhide M, He S, Ren X.

Cardiovasc Toxicol. 2005;5(2):183-202. Review.

PMID:
16046793
17.
18.

Integrating cell-signalling pathways with NF-kappaB and IKK function.

Perkins ND.

Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62. Review.

PMID:
17183360
19.

Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.

Reuter S, Charlet J, Juncker T, Teiten MH, Dicato M, Diederich M.

Ann N Y Acad Sci. 2009 Aug;1171:436-47. doi: 10.1111/j.1749-6632.2009.04731.x.

PMID:
19723087
Items per page

Supplemental Content

Support Center